Body Fluid Collection And Diagnostics Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services, Instruments), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030

Body Fluid Collection And Diagnostics Market Size, Share & Trends Analysis Report By Sample (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services, Instruments), By Technology, By Application, By Region, And Segment Forecasts, 2025 - 2030


Body Fluid Collection And Diagnostics Market Growth & Trends

The global body fluid collection and diagnostics market size is expected to reach USD 50.18 billion by 2030, registering a CAGR of 6.6% from 2025 to 2030, as per the new report by Grand View Research, Inc. owing to the growing prevalence of non-communicable and communicable diseases globally coupled with growing demand for rapid diagnostic tests for early detection of diseases. In May 2022, TECHKON developed a new method and device which could analyze body fluids and determine medical parameters and instantly diagnose diseases.

Furthermore, body fluid testing is mostly adopted by clinicians to help assess substantial information in regard to patients’ medical conditions, such as infection, inflammatory diseases, malignancy, and hemorrhage. Body fluid analysis is manually performed with optical microscopy, which is a gold-standard approach for cell counting. However, new automated methods for analysis have been introduced which have enhanced precision, and turnaround time, and have reduced inter-operator variability. Automatic analyzers offer improved efficiency, standardization, and accuracy along with accurate, reliable, and rapid counting of WBCs (differential) and red blood cells (RBCs) in cerebrospinal and other body fluids.

The increasing demand for Direct-to-Consumer testing (DTC) is projected to boost the demand for body fluid collection and would enable easy sample collection by end users. Several players offer the DTC sample collection kits to consumers directly and thus analyze the collected samples. For instance, in April 2022, Labcorp launched an innovative healthcare service with Getlabs that aims to easily test consumers at their homes. People can schedule a home blood specimen collection when it’s suitable for them.

Key players operating in the body fluid collection and diagnostics market are considering several initiatives such as entering into a strategic alliance, new product launches, and regional expansion among others. For instance, in December 2022, Roche announced receiving U.S. FDA authorization for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays. These assays would be used to measure biomarkers for Alzheimer’s disease. Similarly, in October 2022, C?N Diagnostics announced the success of the PrecivityAD Blood Test which can assist clinicians in Alzheimer’s disease diagnosis.

Body Fluid Collection And Diagnostics Market Report Highlights
  • The overall growth of the market is attributed to the growing adoption of at-home sample collection tests and the easy availability of diagnostic kits for customers
  • By sample type, the blood segment dominated the market in 2024, owing to the introduction of advanced techniques such as short tandem repeat, single-nucleotide polymorphism analysis, and others
  • By technology, the Polymerase Chain Reaction (PCR) segment dominated the market owing to the growing application of the technology for the detection of diseases. Moreover, the COVID-19 pandemic has also contributed to the market’s growth
  • By application, the diagnostics and monitoring segment dominated the body fluid collection and diagnostics market in 2022 as it helps clinicians to identify changes to cellular networks and physiological conditions in diseased tissues
  • By product, the kits and consumables segment captured the highest share in 2024, owing to increasing demand for rapid and cost-effective kits coupled with easing government regulations
  • North America dominated the market in 2024 due to the presence of several market players in the region coupled with increasing product launches and strategic initiatives
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Sample
1.2.2. Product
1.2.3. Technology
1.2.4. Application
1.2.5. Regional scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Sample Outlook
2.2.2. Product outlook
2.2.3. Technology outlook
2.2.4. Application outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Body Fluid Collection And Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing adoption of body fluid and collection kits for rapid diagnosis
3.2.1.2. Increasing prevalence of non-communicable diseases
3.2.1.3. Technological Advancements in Diagnostic Testing
3.2.2. Market restraint analysis
3.2.2.1. Lack of expertise to conduct at-home testing
3.2.2.2. High cost of instruments
3.3. Body Fluid Collection And Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Body Fluid Collection And Diagnostics Market: Sample Estimates & Trend Analysis
4.1. Sample Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Body Fluid Collection And Diagnostics Market by Sample Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Blood
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Saliva
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Urine
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Cerebrospinal Fluid
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Body Fluid Collection And Diagnostics Market: Product Estimates & Trend Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Segment Dashboard
5.3. Global Body Fluid Collection And Diagnostics Market by Product Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Tests/Services
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Kits & Consumables
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Instruments
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Body Fluid Collection And Diagnostics Market: Technology Estimates & Trend Analysis
6.1. Technology Market Share, 2024 & 2030
6.2. Segment Dashboard
6.3. Global Body Fluid Collection And Diagnostics Market by Technology Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4.1. Next-Generation Sequencing
6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.2. Polymerase Chain Reaction (PCR)
6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.3. Fluorescence in situ hybridization (FISH)
6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.4.4. Others
6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Body Fluid Collection And Diagnostics Market: Application Estimates & Trend Analysis
7.1. Application Market Share, 2024 & 2030
7.2. Segment Dashboard
7.3. Global Body Fluid Collection And Diagnostics Market by Application Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.4.1. Diagnostics & Monitoring
7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Therapeutic Decision Making
7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. Prognostics & Screening
7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Body Fluid Collection And Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
8.6.3. France
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework/ reimbursement structure
8.6.3.3. Competitive scenario
8.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
8.6.4. Italy
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework/ reimbursement structure
8.6.4.3. Competitive scenario
8.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
8.6.5. Spain
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework/ reimbursement structure
8.6.5.3. Competitive scenario
8.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
8.6.6. Norway
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework/ reimbursement structure
8.6.6.3. Competitive scenario
8.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key country dynamics
8.6.7.2. Regulatory framework/ reimbursement structure
8.6.7.3. Competitive scenario
8.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
8.6.8. Denmark
8.6.8.1. Key country dynamics
8.6.8.2. Regulatory framework/ reimbursement structure
8.6.8.3. Competitive scenario
8.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. Japan
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
8.7.4. Australia
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
8.7.5. South Korea
8.7.5.1. Key country dynamics
8.7.5.2. Regulatory framework/ reimbursement structure
8.7.5.3. Competitive scenario
8.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
8.7.6. Thailand
8.7.6.1. Key country dynamics
8.7.6.2. Regulatory framework/ reimbursement structure
8.7.6.3. Competitive scenario
8.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework/ reimbursement structure
8.8.1.3. Competitive scenario
8.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
8.8.2. Argentina
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework/ reimbursement structure
8.8.2.3. Competitive scenario
8.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. South Africa
8.9.1.1. Key country dynamics
8.9.1.2. Regulatory framework/ reimbursement structure
8.9.1.3. Competitive scenario
8.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
8.9.2. Saudi Arabia
8.9.2.1. Key country dynamics
8.9.2.2. Regulatory framework/ reimbursement structure
8.9.2.3. Competitive scenario
8.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
8.9.3. UAE
8.9.3.1. Key country dynamics
8.9.3.2. Regulatory framework/ reimbursement structure
8.9.3.3. Competitive scenario
8.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
8.9.4. Kuwait
8.9.4.1. Key country dynamics
8.9.4.2. Regulatory framework/ reimbursement structure
8.9.4.3. Competitive scenario
8.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.3. Vendor Landscape
9.3.1. Key company market share analysis, 2024
9.3.2. Thermo Fisher Scientific Inc.
9.3.2.1. Company overview
9.3.2.2. Financial performance
9.3.2.3. Product benchmarking
9.3.2.4. Strategic initiatives
9.3.3. Bio-Rad Laboratories
9.3.3.1. Company overview
9.3.3.2. Financial performance
9.3.3.3. Product benchmarking
9.3.3.4. Strategic initiatives
9.3.4. Illumina, Inc
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Guardant Health
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. QIAGEN
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Johnson & Johnson
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. Laboratory Corporation of America Holdings
9.3.8.1. Company overview
9.3.8.2. Financial performance
9.3.8.3. Product benchmarking
9.3.8.4. Strategic initiatives
9.3.9. Biocept Inc
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. F. Hoffmann-La Roche Ltd.
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. MDxHealth SA.
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings